POPPY: Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse

Sponsor
Glasgow Caledonian University (Other)
Overall Status
Completed
CT.gov ID
NCT00476892
Collaborator
Chief Scientist Office of the Scottish Government (Other), South Glasgow University Hospitals NHS Trust (Other), University of Aberdeen (Other), University of Otago (Other)
448
28
2
45
16
0.4

Study Details

Study Description

Brief Summary

The aim of this study is to determine the effectiveness and cost-effectiveness of pelvic floor muscle training in the management of pelvic organ prolapse in women.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pelvic Floor Muscle Training
N/A

Detailed Description

Pelvic organ prolapse is a common problem that adversely affects the daily activities and quality of life of many women. Pelvic floor muscle training interventions are commonly used by physiotherapists to manage prolapse. However, a Cochrane review found limited evidence to support the effectiveness of such interventions. Based on the findings of a successful feasibility study, this multi-centre randomised controlled trial will address the paucity of evidence. 556 symptomatic women with diagnosed prolapse will be enrolled in 16 UK centres and 1 New Zealand centre over 16 months and randomised to pelvic floor muscle training plus lifestyle advice, or to receive a lifestyle leaflet only. Principal measures of outcome are: prolapse symptoms, prolapse severity, and subsequent further treatment up to 12 months after trial entry.

Study Design

Study Type:
Interventional
Actual Enrollment :
448 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
A Multi-centre Randomised Controlled Trial of a Pelvic Floor Muscle Training Intervention for Women With Pelvic Organ Prolapse
Study Start Date :
Jun 1, 2007
Actual Primary Completion Date :
Jul 1, 2010
Actual Study Completion Date :
Mar 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Other: 1

It consists of five outpatient appointments (weeks 0, 2, 6, 11 and 16) with a local trial physiotherapist at a trial centre. At the first appointment a standardised history is taken from the woman, anatomy and function of the pelvic floor muscles are taught, and types of prolapse described, using diagrams and a model pelvis. Women are taught how to contract the muscles, and also how to contract and hold prior to an event that increases intra-abdominal pressure ("the Knack"). Pelvic floor muscles are assessed by vaginal examination and recorded on a dedicated form at each appointment thus determining the content of a single set of exercises for each woman. At least three sets of exercises daily is recommended. Women use an exercise diary to record compliance. Tailored advice is given on ways of reducing intra-abdominal pressure, e.g. advice on weight loss, chronic cough, heavy lifting and general exercise.

Procedure: Pelvic Floor Muscle Training
Women in the intervention group attend 5 physiotherapy sessions. At each appointment a clinical history is taken, pelvic floor muscle assessment carried out, exercises taught and prescribed, and appropriate lifestyle advice given. At the first of these appointments a detailed explanation of the pelvic anatomy and different types of prolapse is given.

No Intervention: 2

Women allocated to the control group will be sent a lifestyle advice leaflet only, and will have no planned contact with the centre until their consultant review appointment at six months. The leaflet gives instructions on seeking advice where appropriate about weight loss, constipation, and avoidance of heavy lifting, coughing and high impact exercise, with a view to minimising increases in intra-abdominal pressure which may cause prolapse to worsen.

Outcome Measures

Primary Outcome Measures

  1. Prolapse symptom score (questions developed in feasibility study and undergoing validation). Primary economic outcome measures are: use of health services, average number of days of prolapse symptoms and further prolapse treatment needed/received [1 year]

Secondary Outcome Measures

  1. Prolapse-related quality of life, prolapse severity, need for further prolapse treatment. Other outcomes include: lifestyle changes, urinary symptoms, bowel symptoms, sexual symptoms, general health status. [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • New attendee at outpatient gynaecology clinic

  • Any type of prolapse

Exclusion Criteria:
  • Stage 0 or IV prolapse

  • Women reporting no symptoms of prolapse

  • Previous treatment for prolapse (surgery or formal instruction in Pelvic Floor Muscle Training [PMFT,]unless completed more than 5 years ago, pessary, unless pessary removed more than 12 months ago)

  • Unable to comply with PFMT

  • women who have urogenital atrophy requiring treatment with local oestrogens (after an 8 week course of local oestrogen such women can be included);

  • Pregnant or less than 6 months post-natal

  • Unable to give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 St George Hospital Sydney Australia
2 Antrim Area Hospital Antrim Ireland
3 Belfast City Hospital Belfast Ireland BT9 7AB
4 Dunedin School of Medicine Dunedin New Zealand P O Box 913
5 Crosshouse Hospital / Ayrshire Maternity Hospital Kilmarnock Ayrshire United Kingdom KA2 0BE
6 Forth Park Hospital Kirkcaldy Fife United Kingdom KY2 5RA
7 Aberdeen Royal Infirmary Aberdeen Grampian United Kingdom AB25 2ZN
8 North Hampshire Hospitals NHS Trust Basingstoke Hampshire United Kingdom RG24 9NA
9 Royal Infirmary of Edinburgh Edinburgh Lothian United Kingdom EH16 4SA
10 St John's Hospital Livingston West Lothian United Kingdom EH54 6PP
11 Birmingham Women's Hospital Birmingham United Kingdom B15 2TG
12 Bradford Royal Infirmary Bradford United Kingdom BD9 6RJ
13 Addenbrooke's Hospital Cambridge United Kingdom CB2 8AF
14 Chester Hospital Chester United Kingdom CH2 1UL
15 St Richard's Hospital Chichester United Kingdom
16 Ninewells Hospital Dundee United Kingdom DD1 9SY
17 Falkirk and District Royal Infirmary Falkirk United Kingdom FK1 5QE
18 Western Infirmary Glasgow United Kingdom G11 6NT
19 Glasgow Royal Infirmary Glasgow United Kingdom G4 0SF
20 Victoria Infirmary Glasgow United Kingdom G42 9TY
21 Southern General Hospital Glasgow United Kingdom G51 4TF
22 Castle Hill Hospital Hull United Kingdom
23 St James's University Hospital Leeds United Kingdom
24 St Mary's Hospital Manchester United Kingdom M13 OJH
25 Borders General Hospital Melrose United Kingdom TD6 9BS
26 James Cook University Hospital Middlesbrough United Kingdom
27 Worcestershire Royal Hospital Worcester United Kingdom WR5 1DD
28 York Hospital York United Kingdom

Sponsors and Collaborators

  • Glasgow Caledonian University
  • Chief Scientist Office of the Scottish Government
  • South Glasgow University Hospitals NHS Trust
  • University of Aberdeen
  • University of Otago

Investigators

  • Principal Investigator: Suzanne Hagen, NMAHP Research Unit, Glasgow Caledonian University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00476892
Other Study ID Numbers:
  • CZH/4/377
  • ISRCTN35911035
First Posted:
May 22, 2007
Last Update Posted:
Mar 23, 2011
Last Verified:
Feb 1, 2010

Study Results

No Results Posted as of Mar 23, 2011